Company
Structure Therapeutics
Structure Therapeutics Inc.
Public (NASDAQ:GPCR) · South San Francisco, California, USA · Last verified Aug 15, 2024
Structure-based drug design company developing oral small-molecule GLP-1R agonist GSBR-1290.
Company profile
- Legal name
- Structure Therapeutics Inc.
- Status
- public
- Ticker
- NASDAQ:GPCR
- Headquarters
- South San Francisco, California, USA
- Website
- www.structuretx.com
Active assets
| Asset | Stage | Indications |
|---|---|---|
| GSBR-1290 | Phase 2 | — |
Trial roll-up
View all →| Registry ID | Phase | Title | Status |
|---|---|---|---|
| StructureTx-GSBR1290-Ph1 | Phase 1 | A Study of GSBR-1290 in Healthy Participants and Participants With Type 2 Diabetes | Completed |